METTL14 and thyroid gland carcinoma: Moreover, Wang et al. (2020b) found that the expression of METTL3, YTHDC1, FTO, METTL14, RBM15, YTHDF3, WTAP, HNRNPA2B1, ALKBH5, METTL16, YTHDC2, KAA1429, IGF2BP3, RBM15B, and YTHDF1 was significantly lower in thyroid cancer tissues than that in normal thyroid tissues using bioinformatics analysis, consistent with the findings of Hou et al. (2020).